{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:09:34Z","timestamp":1766138974722,"version":"3.48.0"},"reference-count":33,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/gfsg6634","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:18:36Z","timestamp":1732853916000},"page":"6867-6888","source":"Crossref","is-referenced-by-count":1,"title":["Preliminary exploration of the role of CD14 mRNA in coronary artery injury in Kawasaki disease"],"prefix":"10.62347","volume":"16","author":[{"given":"Kun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/VHRM.S291762","article-title":"Kawasaki disease: pathology, risks, and management","volume":"18","author":"Seki","year":"2022","unstructured":"Seki M and Minami T. Kawasaki disease: pathology, risks, and management. Vasc Health Risk Manag 2022; 18: 407-416.","journal-title":"Vasc Health Risk Manag"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/ced.14558","article-title":"Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology","volume":"46","author":"Piram","year":"2021","unstructured":"Piram M and Burns JC. Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology. Clin Exp Dermatol 2021; 46: 503-509.","journal-title":"Clin Exp Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"13948","DOI":"10.3390\/ijms241813948","article-title":"Diagnosis, progress, and treatment update of Kawasaki disease","volume":"24","author":"Kuo","year":"2023","unstructured":"Kuo HC. Diagnosis, progress, and treatment update of Kawasaki disease. Int J Mol Sci 2023; 24: 13948.","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2174\/1381612829666230609162009","article-title":"Clinical characteristics of Kawasaki disease in children with different age groups: a literature review and retrospective study","volume":"29","author":"Huang","year":"2023","unstructured":"Huang B, Tan W, Liao S and Jiang W. Clinical characteristics of Kawasaki disease in children with different age groups: a literature review and retrospective study. Curr Pharm Des 2023; 29: 1516-1523.","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/00494755221081598","article-title":"Kawasaki disease with peripheral and facial gangrene: a case report and review of literature","volume":"52","author":"Madan","year":"2022","unstructured":"Madan D, Maheshwari A, Mahto D, Mendiratta V and Sharma S. Kawasaki disease with peripheral and facial gangrene: a case report and review of literature. Trop Doct 2022; 52: 449-452.","journal-title":"Trop Doct"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/archdischild-2019-317070","article-title":"Kawasaki disease: origins and evolution","volume":"106","author":"Kainth","year":"2021","unstructured":"Kainth R and Shah P. Kawasaki disease: origins and evolution. Arch Dis Child 2021; 106: 413-414.","journal-title":"Arch Dis Child"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00431-022-04458-z","article-title":"Acute phase of Kawasaki disease: a review of national guideline recommendations","volume":"181","author":"Scherler","year":"2022","unstructured":"Scherler L, Haas NA, Tengler A, Pattathu J, Mandilaras G and Jakob A. Acute phase of Kawasaki disease: a review of national guideline recommendations. Eur J Pediatr 2022; 181: 2563-2573.","journal-title":"Eur J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Gupta A. Kawasaki disease and infections: a myth or a reality? Indian J Pediatr 2022; 89: 747-748.","DOI":"10.1007\/s12098-022-04284-z"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.33549\/physiolres.934672","article-title":"Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome","volume":"71","author":"Bordea","year":"2022","unstructured":"Bordea MA, Costache C, Grama A, Florian AI, Lupan I, Samasca G, Deleanu D, Makovicky P, Makovicky P and Rimarova K. Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome. Physiol Res 2022; 71: 17-27.","journal-title":"Physiol Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s00246-021-02633-x","article-title":"Red blood cell distribution width as a predictive marker for coronary artery lesions in patients with Kawasaki disease","volume":"42","author":"Ming","year":"2021","unstructured":"Ming L, Cao HL, Li Q and Yu G. Red blood cell distribution width as a predictive marker for coronary artery lesions in patients with Kawasaki disease. Pediatr Cardiol 2021; 42: 1496-1503.","journal-title":"Pediatr Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The nuclear factor kappa B (NF-κB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","unstructured":"Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA and Miri SR. The nuclear factor kappa B (NF-κB) signaling in cancer development and immune diseases. Genes Dis 2021; 8: 287-297.","journal-title":"Genes Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.gendis.2023.06.016","article-title":"Recent advances of mechanosensitive genes in vascular endothelial cells for the formation and treatment of atherosclerosis","volume":"11","author":"Li","year":"2023","unstructured":"Li S, Xu Z, Wang Y, Chen L, Wang X, Zhou Y, Lei D, Zang G and Wang G. Recent advances of mechanosensitive genes in vascular endothelial cells for the formation and treatment of atherosclerosis. Genes Dis 2023; 11: 101046.","journal-title":"Genes Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"14218","DOI":"10.3390\/ijms241814218","article-title":"The role of NF-κB in intracranial aneurysm pathogenesis: a systematic review","volume":"24","author":"Khan","year":"2023","unstructured":"Khan D, Cornelius JF and Muhammad S. The role of NF-κB in intracranial aneurysm pathogenesis: a systematic review. Int J Mol Sci 2023; 24: 14218.","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/imm.13634","article-title":"Role of CD14 in human disease","volume":"169","author":"Sharygin","year":"2023","unstructured":"Sharygin D, Koniaris LG, Wells C, Zimmers TA and Hamidi T. Role of CD14 in human disease. Immunology 2023; 169: 260-270.","journal-title":"Immunology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cytogfr.2023.08.008","article-title":"Multifaceted role of CD14 in innate immunity and tissue homeostasis","volume":"74","author":"Na","year":"2023","unstructured":"Na K, Oh BC and Jung Y. Multifaceted role of CD14 in innate immunity and tissue homeostasis. Cytokine Growth Factor Rev 2023; 74: 100-107.","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2147\/JIR.S293993","article-title":"Altered monocyte subsets in Kawasaki disease revealed by single-cell RNA-sequencing","volume":"14","author":"Geng","year":"2021","unstructured":"Geng Z, Tao Y, Zheng F, Wu L, Wang Y, Wang Y, Sun Y, Fu S, Wang W, Xie C, Zhang Y and Gong F. Altered monocyte subsets in Kawasaki disease revealed by single-cell RNA-sequencing. J Inflamm Res 2021; 14: 885-896.","journal-title":"J Inflamm Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"166707","DOI":"10.1016\/j.bbadis.2023.166707","article-title":"Single cell RNA-seq resolution revealed CCR1+\/SELL+\/XAF+ CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19","volume":"1869","author":"Liu","year":"2023","unstructured":"Liu X, Luo T, Fan Z, Li J, Zhang Y, Lu G, Lv M, Lin S, Cai Z, Zhang J, Zhou K, Guo J, Hua Y, Zhang Y and Li Y. Single cell RNA-seq resolution revealed CCR1+\/SELL+\/XAF+ CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19. Biochim Biophys Acta Mol Basis Dis 2023; 1869: 166707.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Aguilar Briseño JA, Ramos Pereira L, van der Laan M, Pauzuolis M, Ter Ellen BM, Upasani V, Moser J, de Souza Ferreira LC, Smit JM and Rodenhuis-Zybert IA. TLR2 axis on peripheral blood mononuclear cells regulates inflammatory responses to non-infectious immature dengue virus particles. PLoS Pathog 2022; 18: e1010499.","DOI":"10.1371\/journal.ppat.1010499"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"154268","DOI":"10.1016\/j.phymed.2022.154268","article-title":"Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine","volume":"104","author":"Yang","year":"2022","unstructured":"Yang HY, Liu ML, Luo P, Yao XS and Zhou H. Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine. Phytomedicine 2022; 104: 154268.","journal-title":"Phytomedicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s10753-019-01121-y","article-title":"Salidroside restores an anti-inflammatory endothelial phenotype by selectively inhibiting endothelial complement after oxidative stress","volume":"43","author":"Wang","year":"2020","unstructured":"Wang Y, Su Y, Lai W, Huang X, Chu K, Brown J and Hong G. Salidroside restores an anti-inflammatory endothelial phenotype by selectively inhibiting endothelial complement after oxidative stress. Inflammation 2020; 43: 310-325.","journal-title":"Inflammation"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"153208","DOI":"10.1016\/j.phymed.2020.153208","article-title":"Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: an overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease","volume":"70","author":"Tang","year":"2020","unstructured":"Tang B, Lo HH, Lei C, U KI, Hsiao WW, Guo X, Bai J, Wong VK and Law BY. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: an overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease. Phytomedicine 2020; 70: 153208.","journal-title":"Phytomedicine"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT and Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135: e927-e999.","DOI":"10.1161\/CIR.0000000000000484"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1016575","DOI":"10.3389\/fimmu.2022.1016575","article-title":"MicroRNAs in Kawasaki disease: an update on diagnosis, therapy and monitoring","volume":"13","author":"Xiong","year":"2022","unstructured":"Xiong Y, Xu J, Zhang D, Wu S, Li Z, Zhang J, Xia Z, Xia P, Xia C, Tang X, Liu X, Liu J and Yu P. MicroRNAs in Kawasaki disease: an update on diagnosis, therapy and monitoring. Front Immunol 2022; 13: 1016575.","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/iid3.373","article-title":"Five immune-gene-signatures participate in the development and pathogenesis of Kawasaki disease","volume":"9","author":"Nie","year":"2021","unstructured":"Nie H, Wang S, Wu Q, Xue D and Zhou W. Five immune-gene-signatures participate in the development and pathogenesis of Kawasaki disease. Immun Inflamm Dis 2021; 9: 157-166.","journal-title":"Immun Inflamm Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6062436","DOI":"10.1155\/2020\/6062436","article-title":"The blood gene expression signature for Kawasaki disease in children identified with advanced feature selection methods","volume":"2020","author":"Hu","year":"2020","unstructured":"Hu B, Li Y, Wang G and Zhang Y. The blood gene expression signature for Kawasaki disease in children identified with advanced feature selection methods. Biomed Res Int 2020; 2020: 6062436.","journal-title":"Biomed Res Int"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Wang L, Zeng X and Chen B. Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease. Medicine (Baltimore) 2023; 102: e34939.","DOI":"10.1097\/MD.0000000000034939"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.3390\/ijms241310542","article-title":"Atheroma-relevant 7-oxysterols differentially upregulate Cd14 expression","volume":"24","author":"Kim","year":"2023","unstructured":"Kim BY, Son Y, Kim BJ, Chung SW, Lee D, Eo SK and Kim K. Atheroma-relevant 7-oxysterols differentially upregulate Cd14 expression. Int J Mol Sci 2023; 24: 10542.","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08923973.2021.2017453","article-title":"Immunomodulatory effects of Inonotus obliquus polysaccharide on splenic lymphocytes infected with Toxoplasma gondii via NF-κB and MAPKs pathways","volume":"44","author":"Sang","year":"2022","unstructured":"Sang R, Sun F, Zhou H, Wang M, Li H, Li C, Sun X, Zhao X and Zhang X. Immunomodulatory effects of Inonotus obliquus polysaccharide on splenic lymphocytes infected with Toxoplasma gondii via NF-κB and MAPKs pathways. Immunopharmacol Immunotoxicol 2022; 44: 129-138.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0022034520949486","article-title":"The ubiquitin system and A20: implications in health and disease","volume":"100","author":"Mooney","year":"2021","unstructured":"Mooney EC and Sahingur SE. The ubiquitin system and A20: implications in health and disease. J Dent Res 2021; 100: 10-20.","journal-title":"J Dent Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","article-title":"Kawasaki disease: pathophysiology and insights from mouse models","volume":"16","author":"Noval Rivas","year":"2020","unstructured":"Noval Rivas M and Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol 2020; 16: 391-405.","journal-title":"Nat Rev Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00246-022-02973-2","article-title":"Association of genetic polymorphisms in Kawasaki disease with the response to intravenous immunoglobulin therapy","volume":"44","author":"Sapountzi","year":"2023","unstructured":"Sapountzi E, Fidani L, Giannopoulos A and Galli-Tsinopoulou A. Association of genetic polymorphisms in Kawasaki disease with the response to intravenous immunoglobulin therapy. Pediatr Cardiol 2023; 44: 1-12.","journal-title":"Pediatr Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"110953","DOI":"10.1016\/j.cbi.2024.110953","article-title":"Protective role of forsythoside B in Kawasaki disease-induced cardiac injury: inhibition of pyroptosis via the SIRT1-NF-κB-p65 signaling pathway","volume":"392","author":"Yang","year":"2024","unstructured":"Yang Y, Wang N, Wang Z, Zhao M, Chen L and Shi Z. Protective role of forsythoside B in Kawasaki disease-induced cardiac injury: inhibition of pyroptosis via the SIRT1-NF-κB-p65 signaling pathway. Chem Biol Interact 2024; 392: 110953.","journal-title":"Chem Biol Interact"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10557-021-07277-w","article-title":"Protective roles of Xijiao Dihuang Tang on coronary artery injury in Kawasaki disease","volume":"37","author":"Zhang","year":"2023","unstructured":"Zhang J, Zhuge Y, Rong X, Ni C, Niu C, Wen Z, Lin H, Chu M and Jia C. Protective roles of Xijiao Dihuang Tang on coronary artery injury in Kawasaki disease. Cardiovasc Drugs Ther 2023; 37: 257-270.","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0159202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:59:38Z","timestamp":1766023178000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0159202.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/gfsg6634","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2024]]}}}